Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Parasites & Vectors
|
January 7, 2022
Regional heterogeneity and unexpectedly high abundance of Cooperia punctata in beef cattle at a northern latitude revealed by ITS-2 rDNA nemabiome metabarcoding
Eranga Lakshitha De Seram, Elizabeth Mary Redman, Felicity Kaye Wills, et al.
Clinical Epigenetics
|
May 5, 2017
The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases
Stacey A Cohen, Ming Yu, Kelsey Baker, et al.
Clinical Lung Cancer
|
August 13, 2017
Paired Phase II Studies of Erlotinib/Bevacizumab for Advanced Bronchioloalveolar Carcinoma or Never Smokers With Advanced Non-Small-cell Lung Cancer: SWOG S0635 and S0636 Trials
Howard L West, James Moon, Antoinette J Wozniak, et al.
Clinical Breast Cancer
|
February 10, 2019
Combined Targeted Therapies for First-line Treatment of Metastatic Triple Negative Breast Cancer-A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy With Bevacizumab and Erlotinib
Lynn Symonds, Hannah Linden, Vijayakrishna Gadi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 6, 2010
Phase II selection design trial of concurrent chemotherapy and cetuximab versus chemotherapy followed by cetuximab in advanced-stage non-small-cell lung cancer: Southwest Oncology Group study S0342
Roy S Herbst, Karen Kelly, Kari Chansky, et al.
The Journal of Infectious Diseases
|
March 29, 2002
Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa
Geoffrey S Gottlieb, Papa Salif Sow, Stephen E Hawes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 7, 2021
Association of different fractionation schedules for prophylactic cranial irradiation with toxicity and brain metastases-free survival in stage III non-small cell lung cancer: A pooled analysis of individual patient data from three randomized trials
Willem J A Witlox, Bram L T Ramaekers, Benjamin Lacas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 8, 2022
Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer
Willem J A Witlox, Bram L T Ramaekers, Benjamin Lacas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 15, 2021
Individual patient data meta-analysis of prophylactic cranial irradiation in locally advanced non-small cell lung cancer
Willem J A Witlox, Bram L T Ramaekers, Benjamin Lacas, et al.
The Oncologist
|
September 20, 2022
KRAS Mutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal Adenocarcinomas
Adam C Diehl, Lindsay M Hannan, David B Zhen, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Parasites & Vectors
|
January 7, 2022
Regional heterogeneity and unexpectedly high abundance of Cooperia punctata in beef cattle at a northern latitude revealed by ITS-2 rDNA nemabiome metabarcoding
Eranga Lakshitha De Seram, Elizabeth Mary Redman, Felicity Kaye Wills, et al.
Clinical Epigenetics
|
May 5, 2017
The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases
Stacey A Cohen, Ming Yu, Kelsey Baker, et al.
Clinical Lung Cancer
|
August 13, 2017
Paired Phase II Studies of Erlotinib/Bevacizumab for Advanced Bronchioloalveolar Carcinoma or Never Smokers With Advanced Non-Small-cell Lung Cancer: SWOG S0635 and S0636 Trials
Howard L West, James Moon, Antoinette J Wozniak, et al.
Clinical Breast Cancer
|
February 10, 2019
Combined Targeted Therapies for First-line Treatment of Metastatic Triple Negative Breast Cancer-A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy With Bevacizumab and Erlotinib
Lynn Symonds, Hannah Linden, Vijayakrishna Gadi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 6, 2010
Phase II selection design trial of concurrent chemotherapy and cetuximab versus chemotherapy followed by cetuximab in advanced-stage non-small-cell lung cancer: Southwest Oncology Group study S0342
Roy S Herbst, Karen Kelly, Kari Chansky, et al.
The Journal of Infectious Diseases
|
March 29, 2002
Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa
Geoffrey S Gottlieb, Papa Salif Sow, Stephen E Hawes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 7, 2021
Association of different fractionation schedules for prophylactic cranial irradiation with toxicity and brain metastases-free survival in stage III non-small cell lung cancer: A pooled analysis of individual patient data from three randomized trials
Willem J A Witlox, Bram L T Ramaekers, Benjamin Lacas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 8, 2022
Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer
Willem J A Witlox, Bram L T Ramaekers, Benjamin Lacas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 15, 2021
Individual patient data meta-analysis of prophylactic cranial irradiation in locally advanced non-small cell lung cancer
Willem J A Witlox, Bram L T Ramaekers, Benjamin Lacas, et al.
The Oncologist
|
September 20, 2022
KRAS Mutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal Adenocarcinomas
Adam C Diehl, Lindsay M Hannan, David B Zhen, et al.
Page
of 4